Literature DB >> 19608650

Absence of estrogen receptor-related-alpha increases osteoblastic differentiation and cancellous bone mineral density.

I Delhon1, S Gutzwiller, F Morvan, S Rangwala, L Wyder, G Evans, A Studer, M Kneissel, B Fournier.   

Abstract

The nuclear orphan receptor human estrogen receptor-related receptor (ERR)-alpha is implicated in bone metabolism. We studied the effect of ERRalpha silencing in human mesenchymal stem cells (hMSCs) during osteoblastogenesis. We found that ERRalpha silencing led to an increase of bone sialoprotein and a decrease of osteopontin mRNA levels, suggesting enhanced osteoblastic differentiation. This was confirmed by an increased ability of hMSCs to deposit calcium. Concomitantly, knockdown of ERRalpha inhibited adipogenesis, resulting in a decrease in adipocyte number and adipocyte marker gene expression. In line with a negative role of ERRalpha in bone metabolism, we found that adult female and male ERRalpha-deficient mice displayed a moderate increase in femoral cancellous bone volume and density. Osteoblast surface was increased and marrow fat volume decreased in these animals. Furthermore, ERRalpha-deficient osteoblasts displayed increased differentiation properties in vitro in line with our observations in hMSCs. In summary, we identified a role for ERRalpha in bone mass regulation by affecting osteoblastic differentiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19608650     DOI: 10.1210/en.2009-0121

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  25 in total

Review 1.  Minireview: nuclear receptor regulation of osteoclast and bone remodeling.

Authors:  Zixue Jin; Xiaoxiao Li; Yihong Wan
Journal:  Mol Endocrinol       Date:  2014-12-30

2.  Estrogen related receptor α-induced adipogenesis is PGC-1β-dependent.

Authors:  Dapeng Ju; Jingjing He; Lili Zhao; Xueli Zheng; Gongshe Yang
Journal:  Mol Biol Rep       Date:  2011-07-06       Impact factor: 2.316

Review 3.  The estrogen-related receptors (ERRs): potential targets against bone loss.

Authors:  Ling Zhang; Jiemin Wong; Jean-Marc Vanacker
Journal:  Cell Mol Life Sci       Date:  2016-08-11       Impact factor: 9.261

4.  Molecular cloning, expression, and stress response of the estrogen-related receptor gene (AccERR) from Apis cerana cerana.

Authors:  Weixing Zhang; Ming Zhu; Ge Zhang; Feng Liu; Hongfang Wang; Xingqi Guo; Baohua Xu
Journal:  Naturwissenschaften       Date:  2016-02-27

Review 5.  Orphan nuclear receptors in breast cancer pathogenesis and therapeutic response.

Authors:  Rebecca B Riggins; Mary M Mazzotta; Omar Z Maniya; Robert Clarke
Journal:  Endocr Relat Cancer       Date:  2010-08-16       Impact factor: 5.678

6.  Osteoblast-Based Therapy-A New Approach for Bone Repair in Osteoporosis: Pre-Clinical Setting.

Authors:  Nadia Samy Mahmoud; Mohamed Ragaa Mohamed; Mohamed Ahmed Mohamed Ali; Hadeer Ahmed Aglan; Khalda Sayed Amr; Hanaa Hamdy Ahmed
Journal:  Tissue Eng Regen Med       Date:  2020-04-28       Impact factor: 4.169

7.  Examination of nuclear receptor expression in osteoblasts reveals Rorβ as an important regulator of osteogenesis.

Authors:  Matthew M Roforth; Gang Liu; Sundeep Khosla; David G Monroe
Journal:  J Bone Miner Res       Date:  2012-04       Impact factor: 6.741

Review 8.  Nuclear receptors in bone physiology and diseases.

Authors:  Yuuki Imai; Min-Young Youn; Kazuki Inoue; Ichiro Takada; Alexander Kouzmenko; Shigeaki Kato
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

9.  The biarylpyrazole compound AM251 alters mitochondrial physiology via proteolytic degradation of ERRα.

Authors:  Susan M Krzysik-Walker; Isabel González-Mariscal; Morten Scheibye-Knudsen; Fred E Indig; Michel Bernier
Journal:  Mol Pharmacol       Date:  2012-10-12       Impact factor: 4.436

10.  Absence of ERRalpha in female mice confers resistance to bone loss induced by age or estrogen-deficiency.

Authors:  Catherine Teyssier; Marlène Gallet; Bénédicte Rabier; Laurent Monfoulet; Julien Dine; Claire Macari; Julie Espallergues; Béatrice Horard; Vincent Giguère; Martine Cohen-Solal; Olivier Chassande; Jean-Marc Vanacker
Journal:  PLoS One       Date:  2009-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.